印杂交:乳腺癌的新兴治疗候选者 (2023-2025年)
1School of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian, Henan, 463000, China.
European journal of medicinal chemistry
|December 4, 2025
概括
印混合物对乳腺癌治疗有前途,比传统化疗提供更好的选择性和更少的副作用. 本综述探讨了它们在克服耐药性和提高治疗结果方面的潜力.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌是导致死亡的主要原因,目前的治疗方法面临药物耐药性和严重的副作用.
- 先进的乳腺癌治疗仍然具有挑战性,重点是控制进展,而不是治愈.
- 印混合物提供了一种新的治疗策略,有可能提高疗效和安全性.
研究的目的:
- 审查近期 (自2023年以来) 关于用于乳腺癌治疗的室内杂交品种的进展.
- 总结它们的结构-活动关系和作用机制.
- 为指导新型基于醇的抗癌剂的合理设计.
主要方法:
- 对2023年以来发表的研究的文献综述.
- 分析内杂交物体的结构-活性关系.
- 对乳腺癌的作用机制的研究.
主要成果:
- 印杂交体表现出协同的抗瘤活性和增强的亚型选择性.
- 这些化合物可以调节关键的致癌途径,克服传统药物的局限性.
- 有希望的临床前和早期临床数据强调了它们的治疗潜力.
结论:
- 印混合物代表了乳腺癌治疗中非常有前途的药物类别.
- 它们的多功能设计允许针对各种乳腺癌亚型进行有针对性的干预.
- 对印杂交的进一步研究对于开发改进的乳腺癌疗法至关重要.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K


